You are here

  • Home
  • Archive
  • Volume 56, Issue 4
  • Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation

Article info

Article menu
Download PDFPDF
Extended reports
Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation

Authors

  • Saskia ten Wolde aDepartments of Rheumatology , band Medical Statistics , cUniversity Hospital Leiden, the NetherlandsDepartment of Rheumatology of Free University Hospital Amsterdam, the Netherlands PubMed articlesGoogle scholar articles
  • Jo Hermans aDepartments of Rheumatology , band Medical Statistics , cUniversity Hospital Leiden, the NetherlandsDepartment of Rheumatology of Free University Hospital Amsterdam, the Netherlands PubMed articlesGoogle scholar articles
  • Ferdinand C Breedveld aDepartments of Rheumatology , band Medical Statistics , cUniversity Hospital Leiden, the NetherlandsDepartment of Rheumatology of Free University Hospital Amsterdam, the Netherlands PubMed articlesGoogle scholar articles
  • Ben A C Dijkmans aDepartments of Rheumatology , band Medical Statistics , cUniversity Hospital Leiden, the NetherlandsDepartment of Rheumatology of Free University Hospital Amsterdam, the Netherlands PubMed articlesGoogle scholar articles
  1. Dr S ten Wolde, Department of Rheumatology, University Hospital Leiden, Building 1, C4R, PO Box 9600, 2300 RC Leiden, the Netherlands.
View Full Text

Citation

ten Wolde S, Hermans J, Breedveld FC, et al
Effect of resumption of second line drugs in patients with rheumatoid arthritis that flared up after treatment discontinuation
Annals of the Rheumatic Diseases 1997;56:235-239.

Publication history

  • Accepted January 14, 1997
  • First published April 1, 1997.
Online issue publication 
January 09, 2022

Copyright information

Annals of the Rheumatic Diseases